IBDEI0C5 ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,5764,0)
 ;;=571.1^^41^489^33
 ;;^UTILITY(U,$J,358.3,5764,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5764,1,4,0)
 ;;=4^571.1
 ;;^UTILITY(U,$J,358.3,5764,1,5,0)
 ;;=5^Hepatitis, ETOH acute
 ;;^UTILITY(U,$J,358.3,5764,2)
 ;;=^2597
 ;;^UTILITY(U,$J,358.3,5765,0)
 ;;=070.59^^41^489^34
 ;;^UTILITY(U,$J,358.3,5765,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5765,1,4,0)
 ;;=4^070.59
 ;;^UTILITY(U,$J,358.3,5765,1,5,0)
 ;;=5^Hepatitis, Other Viral
 ;;^UTILITY(U,$J,358.3,5765,2)
 ;;=Hepatitis, Other Viral^266631
 ;;^UTILITY(U,$J,358.3,5766,0)
 ;;=V08.^^41^489^24
 ;;^UTILITY(U,$J,358.3,5766,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5766,1,4,0)
 ;;=4^V08.
 ;;^UTILITY(U,$J,358.3,5766,1,5,0)
 ;;=5^HIV + Status (Asymptomatic)
 ;;^UTILITY(U,$J,358.3,5766,2)
 ;;=HIV + Status (Asymptomatic)^303392
 ;;^UTILITY(U,$J,358.3,5767,0)
 ;;=042.^^41^489^25
 ;;^UTILITY(U,$J,358.3,5767,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5767,1,4,0)
 ;;=4^042.
 ;;^UTILITY(U,$J,358.3,5767,1,5,0)
 ;;=5^HIV Disease (symptomatic)
 ;;^UTILITY(U,$J,358.3,5767,2)
 ;;=HIV Disease (symptomatic)^266500
 ;;^UTILITY(U,$J,358.3,5768,0)
 ;;=464.00^^41^489^2
 ;;^UTILITY(U,$J,358.3,5768,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5768,1,4,0)
 ;;=4^464.00
 ;;^UTILITY(U,$J,358.3,5768,1,5,0)
 ;;=5^Acute Laryngitis
 ;;^UTILITY(U,$J,358.3,5768,2)
 ;;=Acute Laryngitis^323469
 ;;^UTILITY(U,$J,358.3,5769,0)
 ;;=790.6^^41^489^1
 ;;^UTILITY(U,$J,358.3,5769,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5769,1,4,0)
 ;;=4^790.6
 ;;^UTILITY(U,$J,358.3,5769,1,5,0)
 ;;=5^Abnormal LFT's
 ;;^UTILITY(U,$J,358.3,5769,2)
 ;;=^87228
 ;;^UTILITY(U,$J,358.3,5770,0)
 ;;=780.60^^41^489^20
 ;;^UTILITY(U,$J,358.3,5770,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5770,1,4,0)
 ;;=4^780.60
 ;;^UTILITY(U,$J,358.3,5770,1,5,0)
 ;;=5^Fever
 ;;^UTILITY(U,$J,358.3,5770,2)
 ;;=^336764
 ;;^UTILITY(U,$J,358.3,5771,0)
 ;;=795.51^^41^489^55
 ;;^UTILITY(U,$J,358.3,5771,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5771,1,4,0)
 ;;=4^795.51
 ;;^UTILITY(U,$J,358.3,5771,1,5,0)
 ;;=5^Pos PPD w/o Active TB
 ;;^UTILITY(U,$J,358.3,5771,2)
 ;;=^340572
 ;;^UTILITY(U,$J,358.3,5772,0)
 ;;=482.9^^41^489^53
 ;;^UTILITY(U,$J,358.3,5772,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5772,1,4,0)
 ;;=4^482.9
 ;;^UTILITY(U,$J,358.3,5772,1,5,0)
 ;;=5^Pneumonia,Bacterial
 ;;^UTILITY(U,$J,358.3,5772,2)
 ;;=^12347
 ;;^UTILITY(U,$J,358.3,5773,0)
 ;;=571.42^^41^489^31
 ;;^UTILITY(U,$J,358.3,5773,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5773,1,4,0)
 ;;=4^571.42
 ;;^UTILITY(U,$J,358.3,5773,1,5,0)
 ;;=5^Hepatitis, Autoimunne
 ;;^UTILITY(U,$J,358.3,5773,2)
 ;;=^336610
 ;;^UTILITY(U,$J,358.3,5774,0)
 ;;=795.52^^41^489^54
 ;;^UTILITY(U,$J,358.3,5774,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5774,1,4,0)
 ;;=4^795.52
 ;;^UTILITY(U,$J,358.3,5774,1,5,0)
 ;;=5^Pos GMA Interferon w/o Active TB
 ;;^UTILITY(U,$J,358.3,5774,2)
 ;;=^340573
 ;;^UTILITY(U,$J,358.3,5775,0)
 ;;=682.0^^41^490^6
 ;;^UTILITY(U,$J,358.3,5775,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5775,1,4,0)
 ;;=4^682.0
 ;;^UTILITY(U,$J,358.3,5775,1,5,0)
 ;;=5^Cellulitis Of Face
 ;;^UTILITY(U,$J,358.3,5775,2)
 ;;=^271888
 ;;^UTILITY(U,$J,358.3,5776,0)
 ;;=681.00^^41^490^7
 ;;^UTILITY(U,$J,358.3,5776,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5776,1,4,0)
 ;;=4^681.00
 ;;^UTILITY(U,$J,358.3,5776,1,5,0)
 ;;=5^Cellulitis Of Finger NOS
 ;;^UTILITY(U,$J,358.3,5776,2)
 ;;=^271883
 ;;^UTILITY(U,$J,358.3,5777,0)
 ;;=682.7^^41^490^8
 ;;^UTILITY(U,$J,358.3,5777,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5777,1,4,0)
 ;;=4^682.7
 ;;^UTILITY(U,$J,358.3,5777,1,5,0)
 ;;=5^Cellulitis Of Foot
